Edwards Lifesciences Corp (EW)
NYSE: EW · Orthopedic, Prosthetic & Surgical Appliances & Supplies · Irvine, CA · filing with the SEC since 1999
Grade7.2
◀ Past 7.6● Present 7.5▶ Future 6.3
Who owns Edwards Lifesciences Corp
As filed with the SECHolders of 5% or more
2
Vanguard Capital Management holds 7.54% of Common Stock, as its SCHEDULE 13G filed Apr 29, 2026 says.
Directors and officers
18
report now, of 29 people on the record since 2006. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 2 named at left.
Holders of 5% or moreshare of the class, as filed
Vanguard Capital Management
SCHEDULE 13G · filed Apr 29, 2026 · Common Stock
Blackrock, Inc.
SCHEDULE 13G/A · filed Oct 17, 2025 · Common Stock
Wellington Management Group LLP
SCHEDULE 13G/A · filed Aug 12, 2025 · Common Stock · reported falling below 5%
The Vanguard Group
SCHEDULE 13G/A · filed Mar 26, 2026 · Common Stock · reported falling below 5%, from 11.7% in Jan 30, 2025
What EW reports owning in othersstakes of 5% or more, and other ties
Other ties the annual report names
JenaValve Technology, Inc
An investee · investee · invested in, named in the 10-K filed Feb 25, 2026
Medical Device Company August 2022 Investment
An investee · investee · invested in, named in the 10-K filed Feb 25, 2026
Innovalve Bio Medical Limited
A company bought · acquisition · Sep 2024 · owns, named in the 10-K filed Feb 25, 2026
Endotronix, Inc
A company bought · acquisition · Aug 2024 · owns, named in the 10-K filed Feb 25, 2026
JC Medical, Inc.
A company bought · acquisition · Jul 2024 · owns, named in the 10-K filed Feb 25, 2026
7 subsidiaries in 5 countries, from the list filed with the 10-K filed Feb 25, 2026.
Insider tradesForm 4
55sales
0purchases
33sales on a scheduled plan
9people selling
$34.1Msold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Nov 10, 2025 to Nov 10, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2026 runs to Nov 10, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window9 of 29 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Bobo Donald E Jr | CVP,Strategy/Corp Development | 13 | $16.2M | 7 | 0 | $0 |
| Zovighian Bernard J | CEO | 10 | $9.4M | 7 | 0 | $0 |
| Ullem Scott B. | CVP, Chief Financial Officer | 7 | $3.9M | 7 | 0 | $0 |
| Chopra Daveen | CVP, TMTT, Surgical & IHFM | 4 | $3.2M | 0 | 0 | $0 |
| Lippis Daniel J. | CVP, TAVR | 15 | $1.0M | 15 | 0 | $0 |
| Markowitz Wayne | CVP, JAPAC | 5 | $1.0M | 0 | 0 | $0 |
| Bruls Annette | CVP, EMEACLA | 1 | $200,000 | 0 | 0 | $0 |
| Stone Heisz Leslie | director | 1 | $200,000 | 0 | 0 | $0 |
| Dahl Andrew M. | SVP, Corporate Controller | 2 | $100,000 | 0 | 0 | $0 |